INTRODUCTION
Oligodendrocytes (OLs) are the myelinating cells of the CNS and are essential for normal salutatory conduction. OLs in the postnatal forebrain are derived from oligodendrocyte precursors (OPs) that originate from neural stem cells (NSCs) within the subventricular zone (SVZ) of the lateral ventricle (LV). NSCs first give rise to cycling neural progenitors (NPs) (also known as Type-C cells), identified by their expression of the transcription factor (TF) Mash1 and S-phase markers, which then differentiate into OPs or olfactory neurons Marshall et al. 2005; Menn et al. 2006; Nakatani et al. 2013; Richardson et al. 2006) . The mechanisms regulating SVZ-derived OP specification from Type-C cells are unresolved, but are believed to involve specific environmental and transcriptional and cascades (He and Lu 2013) . Postnatally, there is evidence that OPs are derived primarily from the dorsal SVZ (dSVZ), whereas the lateral SVZ (lSVZ) has the greatest neurogenic potential for olfactory neurons (Brill et al. 2009 ; Kessaris et al. 2006; Marshall et al. 2005; Menn et al. 2006; Young et al. 2007 ). Recent studies shed new light on the instructive basis of NSC identities in dSVZ and lSVZ microdomains. For example, FGF2 increases OP proliferation in the dSVZ and ectopically in the lSVZ microdomains during development and into adulthood (Azim et al. 2012b) . These findings complement our recent study showing an early postnatal role for Wnt-β-catenin signaling in regulating NSC specification and oligodenrogenesis in the dorsal SVZ (Azim et al., 2014) , whereas in the adult SVZ Wnt3a strongly increases OL proliferation in the dSVZ without affecting lineage choice or proliferation within neurogenic clones (Ortega et al. 2013) .
MATERIALS AND METHODS

Animals
Mice aged postnatal day (P)8-11 were used throughout. All animal procedures were performed in accordance with the UK Home Office Animals Scientific Procedures Act (1984) . Wild-type mice (C57/BL6) were used and transgenic mice of C57/BL6 background in which fluorescent reporters were driven by Sox10-EGFP mice to identify OPs and OLs as previously characterised (Azim et al. 2012b ).
In vivo injections
Pups of similar size litters were used throughout. Intraventricular injections of the GSK3β inhibitor ARA-014418 (Bhat et al. 2003) were performed daily for 3 days commencing at P8 and brains examined at P11, as previously described (Azim and Butt 2011) . In brief, mice were deeply anaesthetised under isofluorane and ARA-014418 (Sigma-Aldrich) was delivered into the cerebrospinal fluid of the LV using a
Hamilton syringe, at a point 2 mm from the midline along the Bregma, and to a depth of 2 mm. ARA-014418 was stored in DMSO, and diluted in sterile saline vehicle and delivered in a volume of 2 µl; sterile saline/DMSO vehicle was used as controls and referred to as controls only throughout. The growth factors PDGF-AA, IGF1 and FGF2 were used at 5 µg/ml in volumes of 2 µl, as in our previous studies (Azim et al. 2012b; Butt et al. 1997; Goddard et al. 1999) . The growth factors Wnt3a, EGF and BMP4 were used at 2.5 µg/ml in volumes of 2 µl, in accordance with their effective in vitro concentrations in NSC cultures (Lie et al. 2005) , and accounting for the dilution effects of injected agents (Azim and Butt 2011) . Shh was injected at 100 µg/ml in a volume of 2 µls, as previously reported (Jiao and Chen 2008) . Wnt3a, BMP4, IGF1, PDGF-AA and EGF were obtained from R&D Systems, Shh was obtained from eBiosciences and FGF2 obtained from Peprotech, USA.
Immunohistochemistry
Published protocols were followed for immunolabelling (Azim and Butt 2011; Azim et al. 2012b) . In brief, brains were immersion fixed in 4% paraformaldehyde and coronal vibratome sections of 20 µm to 100 µm thickness were cut through the periventricular forebrain. Primary antibodies used were: rabbit anti-PDGFαR (1:400, gift from Prof Stallcup; or 1:100, Abcam); goat anti-PDGFRα(1:200, R&D Systems); rat anti-MBP (1:300, Millipore); mouse anti-Nestin (1:300, BD Biosciences); rabbit anti-Nestin (1:300, R&D Systems); rabbit anti-GFAP (1:300, DAKO); mouse antinuclear pβ-Catenin (1:300, Abcam); goat anti-Tyr216-pGSK3β (1:100, Santa Cruz); goat anti-Ser9-pGSK3β (1:100, Santa Cruz); mouse anti-PCNA (1:400, SigmaAldrich); mouse anti-Mash1 (1:200, BD Biosciences). Appropriate species-matched secondary antibodies conjugated with Alexafluor 488, 568 or 405 (1:500, Molecular Probes) were used. Primary antibodies of different origin were diluted together in blocking buffer and co-dilutions of the appropriate secondary antibodies were used.
Control experiments were performed using appropriate blocking peptides where available or otherwise by omission of the primary antibody. For PCNA or Mash1 labelling, antigen retrieval was performed, whereby free-floating sections were pretreated with PBST and NP-40 1% for 20 mins to permeate the sections, and following washes in PBS, sections were immersed in pre-boiled citric acid and heated in a commercial microwave pressure cooker at full power for 30 sec for 2 
GLIA
cycles. For nuclear β-catenin, Ser9-pGSK3β, and Tyr216-pGSK3β, treated brains were fixed for 3 hrs in Histochoice Fixative (Sigma-Aldrich). PBS was replaced by TBS (0.5M Tris Base, 9% NaCl, pH 8.4) throughout, to reduce non-specific labeling of anti-phospho antibodies. For pGSK3β detection, sections were incubated in Proteinase K (20 µg/ml in TBS, Invitrogen) for 20 mins at 37ºC followed by incubation in 1% SDS for 1 hr at RT and several washing steps. After final washes in PBS, tissues were mounted on poly-lysine coated glass slides with Vectashield mounting media (Vector Laboratories) and sealed with coverslips. Images were acquired using an LSM 5 Pascal Axioskop2 or LSM 510 meta confocal microscope (Zeiss). Fluorescence was visualized at 488nm (green), 568nm (red) and 405nm (blue) using argon, HeNe1 and diode lasers respectively, using a x40 oil immersion lens with high numerical aperture (1.3nm).
Cell counts
Rostral periventricular coronal sections containing the LV were analysed (>3 sections per brain, n>4 animals per group) at rostro-caudal axis 0.6 -0.9 relative to the Bregma; counts of OL and OP cell numbers confirmed that there were no significant differences between sections in untreated controls (Azim and Butt 2011; Azim et al. 2012b) . Images were processed with Zeiss LSM Image Examiner (V. value represents the number of mice and the standard error of the mean (SEM).Cell counts were tested for significance using GraphPad Prism v302, for unpaired t-test (referred to as t-test) or ANOVA followed by Bonferroni's posthoc test as appropriate.
SVZ microdissection and gene expression profiling
Published protocols were followed for microdissection of the SVZ microdomains and subsequent RNA procedures (Azim et al. 2012b ). ARA-014418 or saline/DMSO was injected into the LV as above at P8 and at P9 animals were sacrificed ~2.5 hrs after last treatment by cervical dislocation. A litter of pups were pooled to yield 1 'n' value. (Fei et al. 2010; Ota et al. 2002) . Primers for Notch1-target gene expression (Hes1, Hes3 and Hes5) were selected based on previous studies in OP cultures (Wu et al. 2012; Zhou and Armstrong 2007) . Primer Express 1.5 software was used to design primers and synthesized by Finnzymes. Gene expression data are presented as mean and the SEM, and samples were compared for significance using t-test as above.
SVZ microdissection and western blot
Animals were sacrificed 45 min after the final injection of ARA-014418or vehicle and SVZ microdomains were rapidly microdissected, snap frozen, centrifuged briefly at 4000 x g to obtain tissue pellets for protein extraction in ice cold lysis buffer containing protease inhibitors, as previously described (Azim and Butt 2011) . Lysed tissue supernatant was transferred to Ultrafree MC centrifugal spin columns (Millipore) for separation and concentration of protein extracts above 15KDa.
Purification of cytoplasmic and nuclear extracts were obtained using the "NE-PER and normalised to β-actin or H3 internal controls as appropriate. Experiments were repeated independently at least 3 times and band densitometry values tested for significance using unpaired t-test or ANOVA followed by Bonferroni's posthoc test.
RESULTS
Regional expression and activity of GSK3β β β β in SVZ microdomains
We have shown that GSK3β is implicated in OL differentiation in the developing white matter (Azim and Butt 2011 ), but it is not clear whether GSK3β regulates the generation of OPs in the postnatal SVZ. To examine this, we determined spatiotemporal differences in GSK3β expression by qPCR of microdissected dSVZ and lSVZ compared to corpus callosum (CC) at differing postnatal ages and in the adult. Transcript levels were normalised against GAPDH housekeeping gene by the comparative ∆∆-CT method (Azim et al. 2012b) and expression values compared for statistical significance by ANOVA followed by Bonferroni's test (Fig. 1A,B) . Overall, spatial expression was greatest in the dSVZ at P4 (Fig. 1A ; p<0.05), and in the corpus callosum at P8-P11 ( Fig. 1A ; p<0.05). Levels in the corpus callosum fell markedly in the adult (Fig. 1B, p<0 .01), whereas overall levels were significantly greatest at P8 in both microdomains of the SVZ ( Fig. 1B; p<0.01), although they remained fairly constant at all ages. The results are consistent with GSK3β being most active during the peak period of OL generation in the postnatal forebrain. We tested this directly by measuring GSK3β activity in the SVZ following infusion of the GSK3β inhibitor ARA-014418, as detailed previously (Azim and Butt, 2011; Azim et al., 2014) . GSK3β activity was determined by immunostaining for Ser9-pGSK3β as a marker for the inactive form of GSK3β and Tyr216-GSK3β as a marker for the active form (Cohen and Goedert 2004) . Immunostaining demonstrates GSK3β activity in both dSVZ and lSVZ ( Fig. 1C-F greatest activity at P8-11 in the dSVZ microdomain, the time and site of greatest OP generation postnatally. ARA-014418 is not known to have off-target effects on other kinases (Bhat et al. 2003) as described previously (Azim and Butt, 2011; Azim et al., 2014) .
GSK3β regulates generation of OPs predominantly from the dSVZ microdomain
The data presented above indicates that GSK3β activity is greatest postnatally in the dSVZ microdomain, which a number of studies indicate is the primary source of OPs that migrate to populate the forebrain during this period ). We therefore examined whether GSK3β specifically regulates the generation of OPs in the dSVZ, using transgenic mice in which the lineage-specific transcription factor Sox10 drives the expression of EGFP (Fig. 2) . Inhibition of GSK3β with ARA-014418 markedly increased the density of Sox10-EGFP+ cells in the SVZ and surrounding periventricular white matter (PVWM), compared to controls ( Fig. 2A, B) . Detailed examination of the dSVZ and lSVZ microdomains showed that by far the predominant effect of GSK3β is on the dSVZ, where Sox10-EGFP+ cells were significantly increased 3-fold ( Fig. 2 C, D ,G; p<0.01, t-test) , and in the adjacent PVWM (Fig. 2I ), compared to a small although statistically significant effect on the lSVZ (Fig. 2 E, F, H) . These findings are consistent with GSK3β activity being greatest in the dSVZ microdomain and having a primary role in regulating the generation of OPs from this micodomain, resulting in an increase in the number of OLs in the overlying PVWM.
GSK3β negatively regulates the generation of OPs and neural progenitors (NPs) within specific SVZ microdomains
The results presented above indicate GSK3β activity in the lSVZ, but that its inhibition did not markedly alter OP numbers in this microdomain, suggesting GSK3β mainly regulates OP generation from the dSVZ. Therefore, we next examined the effects of GSK3β inhibition on NSCs and their progeny by qPCR of microdissected microdomains (Fig. 3A-C) and immunostaining ( Fig. 4A-D) . As described previously (Azim et al. 2012a; Azim et al. 2012b ) the SVZ is delineated up to 70 µm from the ependymal wall, based on labelling and aided by nuclear markers.
Transcripts enriched in early SVZ cells, ABCG2 and Nestin, were significantly increased by ARA-014418 in both SVZ microdomains, indicative of an increase in NSCs ( Fig. 3A; p<0.05, t-test), whereas the NP marker Mash1, and the OP markers Olig2 and PDGFRα were differently altered in the two microdomains (Fig. 3B, C) .
Transcripts for Mash1, which is expressed by NPs that generate both neurons and OLs, were significantly increased in both microdomains, but the effect was greatest in the dSVZ, where it was barely detectable in controls and reached expression levels similar to the control lSVZ following GSK3β inhibition (Fig. 3B) . In contrast, GSK3β inhibition markedly increased the OL lineage or OP transcripts Olig2 and PDGFRα respectively, by over 3-fold in the dSVZ ( Fig. 3C ; p<0.01, t-test), with levels in the lSVZ being very low and in the case of PDGFRα not statistically affected by GSK3β inhibition. Immunohistochemical examination of the potential origins of OPs from the dSVZ indicates GFAP+ NSCs and Sox10-EGFP+ cells were segregated populations (Fig.4A,B) . In contrast, GSK3β inhibition resulted in striking increases in the dSVZ of Sox10-EGFP co-expression with the NSC/NP marker Nestin (Doetsch et al. 1997 ) (Fig.4C-E ) and the NP marker Mash1 (Fig. 4F-H 
t-test). These findings indicate that GSK3β regulates
the generation of NP in both the dSVZ and lSVZ, while regulating the generation of OP in a region-specific manner. Cell death was examined using propidium iodide labelling, but in all cases was low in controls and following treatment, in line with our previous study (Azim and Butt et al 2011) .
GSK3β differentially regulates multiple targets in SVZ microdomains
GSK3β is known to modulate several signalling pathways in neural development, most notably Wnt and notch1 pathways (reviewed in (Grimes and Jope 2001; Kim and Snider 2011), which we previously showed were mechanisms by which GSK3β
regulates OL differentiation in the optic nerve (Azim and Butt 2011) . We therefore examined this in the SVZ microdomains using western blot and qPCR (Fig. 5 ). In the P9 SVZ, cytosolic bound β-catenin was increased in both dSVZ and lSVZ microdomains following ARA-014418 (Fig. 5A, B) , whereas nuclear levels of β-catenin were increased to a significantly greater extent in the dSVZ ( Fig. 5C, D; p<0.01, t-test). Moreover, within cytoplasmic extracts, the levels of Erk1/2 were not affected by ARA-014418, indicating it did not have off target effects on other growth factor-related signalling pathways (Fig. 5A ). In addition, we measured nuclear accumulation of the transcription form of Notch1 (NICD), together with BMP signalling via pSMAD1/5/8 and Gli1 for Shh-signalling ( Fig. 5C-E) . Nuclear levels of activated cleaved Notch1 (NCID) were reduced similarly in both SVZ microdomains (p<0.05; t-test), whereas BMP-signalling was only decreased in the dSVZ (p<0.05; ttest), and Gli1 was marginally, but significantly, increased in the lSVZ, consistent with greater Shh expression in this microdomain (p<0.05, t-test) (Azim et al. 2012b; Palma et al. 2005) . These effects were further validated by qPCR of microdissected dSVZ assayed ~2.5 h following ARA-014418infusion (Fig. 5F ). Transcripts for β-catenin target genes cyclin D1, Axin2 and Lef1 were all significantly increased by almost 3-fold in the dSVZ following GSK3β inhibition ( Fig. 5F ; p<0.01, t-test). By comparison, the Notch1 target Hes3 and Hes5 genes were marginally but statistically significantly downregulated, whereas Hes1 was not statistically altered (p<0.05; t-test), as was the case for BMP signalling -Sox4, ID2, Stat1 (Fig. 5F ).
These findings suggest that the predominant effect of inhibiting GSK3β in the dSVZ microdomain is largely attributed to the Wnt pathway, with little effect on other pathways that may regulate oligodendrogenesis in the postnatal SVZ.
FGF2 and Wnt3a act by inhibiting GSK3β
The effects of ARA-014418 demonstrate that endogenous GSK3β regulates the generation of OPs in the postnatal SVZ. Several trophic factors are known to regulate NSC fate and OP differentiation, including FGF2 and Wnt (Azim and Butt, 2011; Azim et al., 2012; Azim et al., 2014) , and so we examined whether these may act to inhibit GSK3β in a manner similar to ARA-014418 (Fig. 6A, C) . Growth factors were infused into the LV of P9 pups and animals sacrificed 45 min later and microdissected dSVZ analysed by western blot of cytosolic extracts for Ser9 pGSK3β. Compared to controls, we found that only FGF2 and Wnt3a inhibited pGSK3β ( Fig. 6A, C; p<0.01, test), and we confirmed that Wnt3a and ARA-014418 acted to increase nuclear β-catenin translocation ( Fig. 6B, D; p<0.01, t-test), as did FGF2, but to a lesser extent (p<0.05; t-test). In addition, EGF appeared to reduce Ser9 pGSK3β via unknown mechanisms, but this was not examined further.
Intriguingly, BMP4 and EGF reduced nuclear β-catenin (p<0.01, t-test) (Fig. 6C, D) , whereas other growth factors (IGF1, PDGF-AA and Shh) did not affect pGSK3β or nuclear β-catenin. Hence, inhibition of GSK3β with ARA-014418 primarily mimics the effects of endogenous canonical Wnts on the dSVZ and to a lesser extent FGF2, consistent with previous findings (Azim et al. 2012b; Azim et al., 2014; Ortega et al. 2013 ). The default source of SVZ-derived oligodendrogenesis under specific demyelinating or growth factor conditions appears to be dSVZ (Azim et al. 2012b; Azim et al., 2014) , consistent with this microdomain in generating most of the forebrain derived OL lineage cells during postnatal development . Inhibiting GSK3β resulted in the preferential genesis of OL lineage cells from the dSVZ, mirroring our previous observations on Wnt signalling and FGF2 (Azim et al. 2012b; Azim et al., 2014) . Furthermore, we provide evidence that FGF2 acts in part to inhibit GSK3β, but not to the same extent as canonical Wnt-signalling. Targeted genetic ablation of GSK3β in NSCs of the developing telencephalon dramatically disrupts neuronal maturation whilst NSCs and cycling NPs are massively upregulated (Kim et al. 2009a ). In comparison, targeted β-catenin expression in later OL lineage cells delays their differentiation (Fancy et al. 2009; Ye et al. 2009 ). In addition, inhibitors for
GSK3β have been used previously in vivo to assess the role of Wnt-signalling in determining cell fate in the SVZ and in NSCs (Adachi et al. 2007; Azim et al., 2014; Kriks et al. 2011; Maurer et al. 2007) . Our findings identify a key role for GSK3β and Wnt/β-catenin in regulating oligodendrogenesis in the forebrain from the proliferating (Mash1+) NPs in the dSVZ microdomain. Adachi et al. (2007) have shown that the increased proliferation observed in the SVZ results in an increase migration of NPs and OPs. Our results suggest that the same might occur in neonates following inhibition of GSK3β, since we observed an increase number of NPs and OPs at some distance (several hundred micrometers from the SVZ), in particular in the dorsolateral corner where many migrating cells converge. Future fate mapping studies will be necessary to address the fate of the extra numerous OPs being produce after GSK3β inhibition
The SVZ microdomains were assayed by western blot and qPCR for the signalling pathways that mediated the increased oligodendrogenesis regulated by GSK3β.
Inhibition of GSK3β increased nuclear translocation of β-catenin specifically in the dSVZ, whereas the activities of Erk1/2, BMP and Shh pathways were not modified, indicating a primary effect on the canonical Wnt/β-catenin signalling, and ruling out possible cross-talk with other growth factor regulated pathways. Moreover, we demonstrated induction of the Wnt target genes Axin2 and Lef1 together with increases in OL lineage markers in the dSVZ following GSK3β inhibition, supporting recent studies on the importance of Wnt-signalling in OP generation from NSC of the doral SVZ microdomain in early postnatal mice (Azim et al., 2014) and adult mice (Ortega et al. 2013) . With respect to neurogenesis from the dSVZ and lSVZ, the effects of GSK3β on Notch1, BMPs and Shh signalling pathways are likely to be important . The Shh activated transcription factor Gli1 was only induced by GSK3β inhibition in the lSVZ, consistent with higher Shh expression in this region at P8 (Azim et al. 2012b; Palma et al. 2005) . A mechanism exists for GSK3β in negatively regulating downstream Shh signalling (Jia et al. 2002) and has been shown in the case of GSK3β ablation in NSCs that promoted Shh signalling at least via Gli1 (Kim et al. 2009a ). In comparison, Notch1 signalling via NICD nuclear activation was reduced dramatically by GSK3β inhibition in the dSVZ compared to the lSVZ, implying a greater role for Notch signalling in regulating oligodendrogenesis and neurogenesis from the dSVZ microdomain. Earlier studies have indicated a direct role for GSK3β in phosphorylating NICD in shortening its halflife (Foltz et al. 2002) , whilst KO of GSK3β in NSCs induces the inverse of promoting Notch1 signalling and its target genes in early forebrain development (Kim et al. 2009a ). In addition, Notch1 activity is required to be downregulated for the timely differentiation of early OL lineage cells (Wang et al. 1998) , which fits with the results of our study where GSK3β inhibition promoted OL lineage progression, as observed previously in the optic nerve (Azim and Butt 2011) . BMPs are strong inhibitors of oligodendrogenesis and their downstream TFs work in concert with β-catenin to repress maturation in later stage OL lineage cells (Bilican et al. 2008; Weng et al. 2012 ). We observed a partial reduction in the downstream BMP pathway factors pSMADs1/5/8 in the dSVZ in response to GSK3β inhibition, which has not previously been reported in the context of SVZ gliogenesis. However, in cultured dorsal spinal cord NPs, FGF2 represses SMADs to induce Olig2 expression (Bilican et al. 2008; Weng et al. 2012) . The results indicate GSK3b regulates multiple pathways that to a certain extent are microdomain specific and may have differential roles in regulating oligodendrogenesis and neurogenesis.
Extracellular cues that could regulate OP generation via GSK3β and β-catenin were examined in the dSVZ. Like ARA-014418, Wnt3a was equally effective in modulating GSK3β and β-catenin implicating that GSK3β functions and effects observed are equivalent to the canonical Wnt pathway (Azim et al., 2014) . Moreover, FGF2
appears to also regulate GSK3β and β-catenin in the dSVZ, as described in cultured
NSCs (Israsena et al. 2004) . Intriguingly, EGF and BMP4 almost completely abolished nuclear β-catenin expression, suggesting they may exert an inhibitory effect on endogenous Wnt/β-catenin signalling in the dSVZ. Neurospheres derived from the dorsal embryonic forebrain rapidly lose Wnt-signalling in conditions containing EGF (Machon et al. 2005) , and EGF-signalling could repress β-catenin or dorsalising NSC phenotypes.
In summary, these findings are line with our previous study showing GSK3β
inhibitors increase the number of OLs and promotes myelination in the developing corpus callosum and following a chemical demyelinating lesion (Azim and Butt 2011) . Our present study provides further evidence that postnatally the dSVZ is the primary source of newly generated OLs in the forebrain, and that their generation from NSC/NP is regulated by endogenous GSK3β activity and Wnt signalling in a microdomain specific manner (Azim et al., 2014) . The failure of remyelination in MS is due in part due to upregulation of negative regulatory factors and a loss of positive regulatory factors (Franklin and Ffrench-Constant 2008) . For example, Notch1 signalling may be upregulated in multiple sclerosis and delay remyelination by inhibiting OPC differentiation (Blanchard et al. 2013; John et al. 2002; Zhang et al. 2009 ). Targeting GSK3β through the use of small molecule inhibitors may therefore complement other therapeutic approaches for stimulating OP generation from the dSVZ. 
